CRESTCHEM LTD.

Crestchem Ltd announced that its Board of Directors met on August 12, 2026, to approve the Unaudited Standalone and Consolidated Financial Results for the Quarter ended June 30, 2026. The results were prepared under Ind AS and accompanied by a Limited Review Report as per SEBI regulations. The board meeting concluded with the approval and recording of these financial statements.

Crestchem Ltd has announced that its Board of Directors will convene on August 12, 2026, at 4:30 PM IST. The primary agenda items include the consideration and approval of the unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026, along with the auditors' report. Additionally, the board will take note of a fine imposed by BSE for the late submission of a consolidated cash flow statement, attributed to the registration of a new subsidiary on March 31, 2026. The meeting will also address any other business with the chair's permission.

Crestchem Ltd has received an email from BSE Limited regarding an outstanding fine of ₹1,06,200 for the late submission of its Cash Flow Statement for Consolidated Results, as required under Regulation 33 of SEBI Listing Regulations. The company clarified that its subsidiary, Oleo Biosciences Private Limited, incorporated on March 31, 2026, had no financial transactions for the period, thus no data was required for the consolidated cash flow statement. Crestchem is seeking a waiver for the fine and believes it will have no material financial impact.

Crestchem Ltd has announced the book closure dates for its 34th Annual General Meeting (AGM) from July 31, 2026, to August 6, 2026. The Board of Directors decided on these dates and the e-voting schedule during a meeting held on July 4, 2026. The AGM is scheduled for August 6, 2026. A dividend of ₹1.50 per share on 30,00,000 equity shares, totaling ₹45,00,000, will be considered, with a record date of July 30, 2026. The company also specified cut-off dates for AGM notice distribution and e-voting.

Crestchem Ltd has clarified that the Escrow Payment Mechanism is not applicable to the company. This follows filings related to the submission of an Escrow Payment Mechanism for disclosing balances in various accounts. The company explicitly stated that it has no such accounts for 'No Lien escrow', 'Interest Payment', 'Sinking Fund', or 'General Account', thus confirming the inapplicability of the mechanism. This information is for record purposes.

Crestchem Ltd announced the revised outcome of its board meeting held on May 29, 2026. The board approved the Audited Standalone & Consolidated Financial Results for the quarter and financial year ended March 31, 2026. Additionally, they noted the formation of a subsidiary, Oleo Biosciences Private Limited, incorporated on March 31, 2026, which has not commenced commercial operations. A final dividend of ₹1.50 per equity share (15%) for FY 2025-26 was recommended, subject to shareholder approval. The board also approved the reappointment and remuneration of Mr. Dipak Narendraprasad Patel, Mrs. Parul Dipak Patel, and Mrs. Tansi Nirmit Patel for five-year terms. Investment up to ₹2.25 Crores in the subsidiary was also approved.

Crestchem Ltd announced the outcome of its Board Meeting held on July 4, 2026. The board has fixed August 6, 2026, as the date for the 34th Annual General Meeting (AGM). Key approvals include the notice for the AGM, the Board of Directors' report, the Corporate Governance report, and the Management Discussion and Analysis Report. Additionally, the company approved opening a dividend account for the financial year 2025-26 and fixed the book closure and record date for dividend payment. The board also decided to arrange a Video Conference Meeting/OVAM with CDSL. The meeting concluded at 2:30 PM.

Crestchem Ltd has announced the closure of its trading window for designated persons, directors, and key management personnel. The window will be closed from July 01, 2026, until 48 hours after the announcement of the unaudited financial results for the first quarter ended June 30, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct, aimed at preventing insider trading during the period leading up to and immediately following the financial results disclosure.

Crestchem Ltd has announced that its Board of Directors will convene on July 4, 2026, to discuss and approve key agenda items. The primary focus will be fixing the date for the 34th Annual General Meeting (AGM) and approving its notice. Other significant matters include the approval of the Board of Directors report, Corporate Governance Report, and the Management Discussion & Analysis Report. The board will also decide on opening a dividend account with HDFC Bank, fixing the book closure and record date for the FY2025-26 dividend, and approving the calendar of events for the AGM. The meeting is scheduled for 12:15 PM.

Crestchem Ltd. has disclosed a sale of 14,600 equity shares by Ms. Sonal Dushyant Patel, a member of the promoter group and sister of promoter Dipak N. Patel. The transaction, executed through open market sales on June 23, 2026, involved 14,600 shares, reducing her holding to 5,295 shares. The total value of the sale amounted to ₹12,96,822. This disclosure is made pursuant to Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015.